Roche, a global pioneer in pharmaceuticals and diagnostics, has launched the CoaguChek INRange system in countries accepting the CE Mark. The CoaguChek INRange system is the first Bluetooth enabled PT ...

Roche Diagnostics has launched a Bluetooth-connected device for testing blood coagulation in Europe. The CoaguChek INRange system has received a CE Mark, and an older version of the device without the ...

However, the CoaguChek Vantus system is a US-specific version of the system. One thing that differs between the two products is the CoaguChek INRange has the option to display test results as INR, PT ...

The CoaguChek INRange system measures patients' prothrombin time (PT) (also known as International Normalised Ratio – INR) levels to check on their anticoagulation status and their response to ...

Earlier this year, Roche launched the CoaguChek INRange system in Europe, which helps patients and doctors monitor coagulation and response to vitamin K antagonist therapy.

Roche Diagnostics announced today it has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for the CoaguChek® XS Pro system, a new point-of-care anticoagulation monitor ...

Roche Diagnostics announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the CoaguChek XS Pro system, a new point-of-care anticoagulation monitor with a ...

Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that ...

Roche announced that it has been granted CLIA-waived status by the FDA for the CoaguChek XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools ...

The CoaguChek XS system is recommended for self‑monitoring coagulation status in adults and children on long‑term vitamin K antagonist therapy who have atrial fibrillation or heart valve disease if: ...